Long-term outcomes of tricuspid valve replacement in the current era

Farzan Filsoufi1, Ani C Anyanwu, Sacha P Salzberg

  • 1Mount Sinai Hospital, New York, New York, USA. farzan.filsoufi@mountsinai.org

Insights

Tricuspid valve replacement (TVR) in high-risk patients has high operative mortality. Mechanical valves showed slightly better long-term survival than bioprosthetic valves, but heart failure remains a key cause of death.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Surgery
  • Prosthetic Valve Outcomes

Background:

  • Tricuspid valve replacement (TVR) is associated with significant mortality and morbidity.
  • High-risk patient populations often require TVR due to complex cardiac conditions.

Purpose of the Study:

  • To evaluate operative mortality, long-term survival, and valve-related events after tricuspid valve replacement.
  • To compare outcomes between bioprosthetic and mechanical valves in a high-risk cohort.

Main Methods:

  • Retrospective analysis of 81 patients undergoing TVR between 1985 and 1999.
  • Patients were categorized by prosthesis type (bioprosthetic vs. mechanical).
  • Risk factors, operative details, and survival data were analyzed.

Main Results:

  • Overall operative mortality was 22%.
  • Mechanical valves demonstrated slightly superior long-term survival compared to bioprosthetic valves.
  • Organic etiology was a predictor of late death.

Conclusions:

  • TVR is performed in high-risk patients with frequent reoperations and comorbidities.
  • High operative and overall mortality persist, with heart failure being the primary cause of death.
  • Timely referral is crucial to prevent end-stage cardiac impairment before TVR.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...